Epicardial Adipose Tissue Thickness PredIcts Obstructive Coronary Artery Disease in Acute Coronary Syndrome Patients

Completed

• Conditions: Acute Coronary Syndrome

• Registration Number: NCT03787797
• Lead Sponsor: University Hospital, Essen

Brief Summary

Epicardial adipose tissue (EAT) is a visceral adipose tissue that surrounds the heart and the coronary arteries. It is metabolically active, secreting pro- and anti-inflammatory mediators and cytokines. With increasing EAT volume, inflammatory activity increasing, which suggests that EAT may locally influence atherosclerosis development in the coronary artery tree. The amount of EAT is associated with cardiovascular disease risk factors as well as presence and progression of subclinical atherosclerosis. Likewise, EAT volume is increased in patient with prevalent and incident coronary artery disease manifestation. In the setting of acute coronary syndrome, EAT was found to be associated with the TIMI risk score and Syntax II score. While CT imaging of the heart is the gold standard for EAT quantification, transthoracic echocardiography allows for a quick and reliable assessment of EAT thickness, as has been used in research studies and may qualify for routine EAT assessment in clinical routine.However, currently data on how quantification of EAT in clinical routine may impact patient management is lacking. We aim to investigate, whether quantification of EAT thickness via transthoracic echocardiography enables improved risk stratification in patients presenting with acute chest pain to the emergency department.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-06
• Study First Submitted: 2018-12-21
• Study First Submitted QC: 2018-12-21
• Study First Posted: 2018-12-26
• Primary Completion: 2020-12-14
• Study Completion: 2022-08-30
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-02
• Last Update Posted: 2022-11-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 657

Inclusion Criteria

• admission to the emergency department of the University Hospital Essen with acute chest pain suggestive of an acute coronary syndrome

Exclusion Criteria

• Known obstructive coronary artery disease prior to presentation, prior revascularization therapy, unwillingness to provide informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Coronary revascularization	within 90 days after initial presentation	Number of Participants with need for coronary revascularization therapy

Secondary Outcome Measures

Name	Time	Method
Invasive coronary angiography	within 90 days after initial presentation	Number of Participants undergoing invasive coronary angiography

Trial Locations

Locations (1)

University Hospital Essen; 🇩🇪 Essen, NRW, Germany